H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Newark have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 311,549. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Newark clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Newark storefront.
Regenerative Medicine for Athletic Performance in Newark, NJ for clinics & physicians. Regenerative medici… Compliance support & pricing — contact Hawk Medical.
Newark is a city of 250k–500k (311,549 Census). CDC PLACES (2023, crude) estimates 14.6% of adults in Newark have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Adult arthritis here is 19.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Regenerative Medicine for Athletic Performance notes (how the product actually works)JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Newark is 14.6% or not. PLACES is planning data. The LCD is the claim.
If you already buy regenerative medicine for athletes elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 14.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 35.9%; arthritis is 19.9%. That is place-level BRFSS modeling, not a clinic census and not a Newark trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Novitas Solutions CTP articles. Mixing those codes is a billing error.
It is the Census city-proper count — useful as scale for a city of 250k–500k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
If you operate in New Jersey and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Newark tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Newark, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Newark is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Newark — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Newark. Useful for joint-program math; still needs a diagnosis and privileging.
No Newark storefront. Joe Bradley is an active practice owner. regenerative medicine for athletes stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.